CAR-T and engineered T cell therapies

Clinical MedicineUpdated Oct 5, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

249 papers

Showing 241-249 of total 249 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2014OpenAlexDirectly related

Marco L. Davila; Isabelle Rivière; Xiuyan Wang; Shirley Bartido; Jae H. Park; Kevin J. Curran; Stephen S. Chung; Jolanta Stefanski; Oriana Bórquez-Ojeda; Malgorzata Olszewska; Jinrong Qu; Teresa Wasielewska; Qing He; Mitsú J. Fink; Himaly Shinglot; Maher Youssif; Mark Satter; Yongzeng Wang; James Hosey; Hilda Quintanilla; Elizabeth Halton; Yvette Bernal; Diana Bouhassira; Maria E. Arcila; Mithat Gönen; Gail J. Roboz; P. Maslak; Dan Douer; Mark G. Frattini; Sergio Giralt; Michel Sadelain; Renier J. Brentjens

Feb 19, 2014Science Translational Medicine

2014OpenAlexDirectly related2,520 citations

Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia

Feb 19, 2014Science Translational Medicine

2013OpenAlexDirectly related875 citations

Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies

Gregory L. Beatty; Andrew R. Haas; Marcela V. Maus; Drew A. Torigian; Michael C. Soulen; Gabriela Plesa; Anne Chew; Yangbing Zhao; Bruce L. Levine; Steven Μ. Albelda; Michael Kalos; Carl H. June

Dec 20, 2013Cancer Immunology Research

2013OpenAlexDirectly related475 citations

Exploiting the curative potential of adoptive T‐cell therapy for cancer

Christian S. Hinrichs; Steven A. Rosenberg

Dec 13, 2013Immunological Reviews

2013OpenAlexDirectly related1,554 citations

The Basic Principles of Chimeric Antigen Receptor Design

Michel Sadelain; Renier J. Brentjens; Isabelle Rivière

Apr 1, 2013Cancer Discovery

2013OpenAlexDirectly related722 citations

Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity

C. B. H. W. Lamers; Stefan Sleijfer; Sabine van Steenbergen; Pascal van Elzakker; Brigitte van Krimpen; C.A.M. van der Velden-de Groot; Arnold G. Vulto; Michael den Bakker; Egbert Oosterwijk; Reno Debets; Jan W. Gratama

Feb 19, 2013Molecular Therapy

2013OpenAlexDirectly related678 citations

B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma

Robert O. Carpenter; Moses O. Evbuomwan; Stefania Pittaluga; Jeremy J. Rose; Mark Raffeld; Shicheng Yang; Ronald E. Gress; Frances T. Hakim; James N. Kochenderfer

Jan 23, 2013Clinical Cancer Research

2011OpenAlexDirectly related3,597 citations

Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia

David L. Porter; Bruce L. Levine; Michael Kalos; Adam Bagg; Carl H. June

Aug 10, 2011New England Journal of Medicine

2007OpenAlexDirectly related557 citations

Adoptive T cell therapy for cancer in the clinic

Carl H. June

Jun 1, 2007Journal of Clinical Investigation